ZNF320 Inhibitors
Chemical inhibitors of ZNF320 can act through various mechanisms to regulate its function by altering its phosphorylation status. Chelerythrine and H-89 serve as inhibitors to protein kinase C (PKC) and protein kinase A (PKA), respectively. PKC and PKA are kinases that can phosphorylate a broad range of substrates, including proteins like ZNF320, which may alter their activity. Inhibition of these kinases by chelerythrine and H-89, therefore, can lead to reduced phosphorylation of ZNF320, affecting its function. Similarly, SB203580, by targeting p38 MAPK, and PD98059 and U0126, both targeting MEK, can inhibit the phosphorylation cascade that could affect ZNF320 activity. The inhibition of these kinases prevents the phosphorylation that is often required for the activation of many proteins within cellular signaling pathways.
Other inhibitors like LY294002 and Rapamycin target upstream kinases such as PI3K and mTOR, respectively. By doing so, they can suppress the activation of downstream kinases that may be involved in the regulation of ZNF320, thereby inhibiting its activity. Moreover, SP600125 inhibits JNK, and PP2 targets Src family tyrosine kinases, both of which are involved in different signaling pathways that can phosphorylate and thereby regulate the function of proteins like ZNF320. Dasatinib, with its broad-spectrum kinase inhibition, can also reduce the phosphorylation of ZNF320 by inhibiting various tyrosine kinases. Staurosporine, another broad-spectrum inhibitor, can affect multiple kinases and therefore broadly inhibit phosphorylation events that would otherwise affect ZNF320 function. Lastly, Bortezomib's inhibition of the proteasome can indirectly affect the stability and localization of ZNF320 by causing an accumulation of ubiquitinated proteins, which may include those involved in ZNF320 regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is known to inhibit protein kinase C (PKC). Since ZNF320 is a zinc finger protein that may be regulated by PKC through phosphorylation, inhibition of PKC by chelerythrine would prevent phosphorylation of ZNF320, leading to its functional inhibition. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAPK, a protein kinase involved in signaling pathways that may regulate proteins like ZNF320. Inhibition of p38 MAPK by SB203580 could lead to decreased phosphorylation and activity of ZNF320. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which is upstream of many signaling pathways, including those that could regulate ZNF320. Inhibition of PI3K by LY294002 can prevent activation of downstream effectors that may be necessary for ZNF320 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which is involved in the ERK pathway. As such, it may inhibit the phosphorylation of proteins that interact with or regulate ZNF320, thereby inhibiting ZNF320's functional activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which may affect signaling pathways involving ZNF320. Inhibition of JNK by SP600125 can lead to a reduction in ZNF320 phosphorylation and activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Src kinases can phosphorylate a variety of substrates, potentially including ZNF320. Inhibition by PP2 can therefore inhibit phosphorylation and subsequent activity of ZNF320. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that could inhibit kinases responsible for phosphorylating ZNF320. This would lead to a reduction in ZNF320 phosphorylation and subsequent inhibition of its activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that could inhibit multiple kinases that phosphorylate ZNF320, leading to functional inhibition of ZNF320 through prevention of its phosphorylation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that could lead to the accumulation of ubiquitinated proteins, which might include signaling molecules that regulate the stability and localization of ZNF320, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is part of signaling pathways that could regulate ZNF320 activity. Inhibition of mTOR by rapamycin can lead to reduced activity of ZNF320 due to decreased phosphorylation of proteins within the pathway. | ||||||